Clinically Important Considerations with the Use of Oral Doxycycline

Main Article Content

James Del Rosso

Keywords

doxycycline, tetracyclines, therapy, therapeutic tips, drug reactions

Abstract

Tetracyclines are the most commonly prescribed oral antibiotics in dermatology. They are used to treat both cutaneous infections and non-infectious inflammatory disorders, the latter often with chronic therapy. Doxycycline may be favored by some dermatologists over minocycline due to a lower risk of certain adverse reactions, especially some with systemic manifestations. The major adverse events that are more common with doxycycline are gastrointestinal side effects, including pill esophagitis, and phototoxicity. This article reviews practical tips when prescribing oral doxycycline, emphasizing suggestions to optimize therapeutic success and reduce untoward reactions.      

References

1. Del Rosso JQ, Webster GF, Rosen T, et al. Status report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society Part 1: antibiotic prescribing patterns, sources of antibiotic exposure, antibiotic consumption and emergence of antibiotic resistance, impact of alterations in antibiotic prescribing, and clinical sequelae of antibiotic use. J Clin Aesthet Dermatol. 2016;9(4):18–24.
2. Kim S, Michaels BD. Kim GK, Del Rosso JQ. Systemic antibacterial agents. In: Wolverton SE, Ed, Comprehensive Dermatologic Drug Therapy, 3rd Edition, Elsevier-Saunders, Philadelphia, Pennsylvania, 2013, pp 61-98.
3. Leyden JJ, Del Rosso JQ. Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. J Clin Aesthet Dermatol. 2011;4(2):40-47.
4. Del Rosso JQ. Topical and oral antibiotics for acne vulgaris. Semin Cutan Med Surg. 2016;35(2):57-61.
5. Del Rosso JQ, Kim GK. Optimizing use of oral antibiotics in acne vulgaris. Dermatol Clin. 2009;27(1):33-42.
6. Korting HC, Schollmann C. Tetracycline actions relevant to rosacea treatment. Skin Pharmacol Physiol. 2009;22(6):287-294.
7. Webster GF, Del Rosso JQ. Anti-inflammatory activity of tetracyclines. Dermatol Clin. 2007;25(2):133-135.
8. Bhatia N. Use of antibiotics for noninfectious dermatologic disorders. Dermatol Clin. 2009;27(1):85-89.
9. Del Rosso JQ, Rosen T, Thiboutot D, et al. Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society Part 3: current perspectives on skin and soft tissue infections with emphasis on methicillin-resistant Staphylococcus aureus, commonly encountered scenarios when antibiotic use may not be needed, and concluding remarks on rational use of antibiotics in dermatology. J Clin Aesthet Dermatol. 2016;9(6):17–24.
10. Del Rosso JQ. A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines. Cutis. 2004;74(2):118-122.
11. Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol. 2006;54(2):258-265.
12. Del Rosso JQ. Oral antibiotics. In: Shalita AR, Del Rosso JQ, Webster GF, Eds, Acne Vulgaris, Informa Healthcare, London, United Kingdom, 2011, pp 113-124.
13. Del Rosso JQ. Systemic therapy for rosacea: focus on oral antibiotic therapy and safety. Cutis. 2000;66(4 Suppl):7-13.
14. Del Rosso JQ. Oral doxycycline in the management of acne vulgaris: current perspectives on clinical use and recent findings with a new double-scored small tablet formulation. J Clin Aesthet Dermatol. 2015;8(5):19-26.
15. Berger RS. A double-blind, multiple-dose, placebo-controlled, cross-over study to compare the incidence of gastrointestinal complaints in healthy subjects given Doryx R and Vibramycin R. J Clin Pharmacol. 1988;28(4):367-370.
16. Del Rosso JQ, Schlessinger J, Werschler P. Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea. J Drugs Dermatol. 2008;7(6):573-576.
17. Kadayifci A, Gulsen MT, Koruk M, et al. Doxycycline-induced pill esophagitis. Dis Esophagus. 2004;17(2):168-171.
18. Dağ MS, Öztürk ZA, Akın I, et al. Drug-induced esophageal ulcers: case series and the review of the literature. Turk J Gastroenterol. 2014;25(2):180-184.
19. Goetze S, Hiernickel C, Elsner P. Photoxicity of doxycycline. Skin Pharmacol Physiol. 2017;30:76-80.
20. Yong CK, Prendiville J, Peacock DL, et al. An unusual presentation of doxycycline-induced photsoensitivity. Pediatrics. 2000;106:E13.
21. Layton AM, Cunliffe WJ. Phototoxic eruptions due to doxycycline – a dose-related phenomenon. Clin Exp Dermatol. 1993;18:425-427.
22. Lim DS, Murphy GM. High-level ultraviolet A photoprotection is needed to prevent doxycycline: lessons learned in East Timor. Br J Dermatol. 2003;149:213-214.
23. Del Rosso JQ. Use of Polypodium leucotomas extract in clinical practice: a primer for the clinician. J Clin Aesthet Dermatol. 2016;9(5):37-42.
24. Del Rosso JQ, Baldwin H, Webster G, et al. American Acne & Rosacea society rosacea medical management guidelines. J Drugs Dermatol. 2008;7(6):531-533.